Delivery Order SPE2DB22D1017-SPE2DB25FG5GD
Award Date 6/18/25
Potential Completion Date 6/20/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,962.87 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide), a diabetes and weight management medication. This firm fixed-price delivery order, awarded September 15, 2025, with completion targeted for September 16, 2025, was executed without a set-aside designation through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,868.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 ml pen injectors on September 11, 2025, with completion expected by September 12, 2025. This non-set-aside contract represents a single delivery order fulfillment for the diabetes and weight management medication, performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award reflects the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order represents a direct purchase of the FDA-approved diabetes and weight management medication through a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to the place of...
- The Defense Logistics Agency awarded a $1,525.16 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by July 16, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply relationship with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $10,380.95 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract involves...
- The Defense Logistics Agency awarded a delivery order valued at $9,140.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $21,963.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on May 6, 2025, with an ultimate completion date of May 7, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase of the diabetes and weight management medication under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide injection) with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...